Detalles de la búsqueda
1.
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(8): 1126-1138, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237250
2.
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors.
Clin Cancer Res
; 28(5): 882-892, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844977
3.
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer.
Thyroid
; 32(5): 515-524, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403447
4.
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
J Biol Chem
; 285(24): 18575-85, 2010 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20360610
5.
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Lab Invest
; 89(3): 301-14, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139719
6.
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.
J Carcinog
; 8: 15, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19955662
7.
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Gynecol Oncol
; 110(1): 49-55, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18423560
8.
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Clin Cancer Res
; 12(24): 7261-70, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17189397
9.
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
J Clin Oncol
; 35(3): 352-360, 2017 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27870570
10.
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
PLoS One
; 8(7): e67668, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23844053
11.
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Clin Lung Cancer
; 13(2): 123-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22100149
12.
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer.
J Thorac Oncol
; 6(1): 109-14, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21107290
13.
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.
J Clin Oncol
; 29(16): 2215-22, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21502556
14.
Generation of comprehensive thoracic oncology database--tool for translational research.
J Vis Exp
; (47)2011 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21304468
15.
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
J Clin Bioinforma
; 1(8): 1-11, 2011 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21603121
16.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Cancer Res
; 69(7): 3021-31, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19318576
17.
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
Cancer Biol Ther
; 7(6): 856-63, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18340114
18.
Protein kinase C beta in malignant pleural mesothelioma.
Anticancer Drugs
; 19(9): 841-8, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18765998
19.
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Arch Pathol Lab Med
; 132(12): 1882-8, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19061284
20.
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Cancer Res
; 68(1): 132-42, 2008 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172305